Novel D-6-n-propylergolines of the formula:
wherein Y is 0 or S and R1 is n-propyl, and pharmaceutically-acceptable acid addition salts thereof can be used to lower the prolactin level in mammals or for treating symptoms of Parkinson's syndrome in humans. A process of preparing the compounds is described which comprises reacting D-6-n-propyl-8a- mesyloxymethylergoline with the sodium salt of methylmercaptan or sodium methylate.
式中 Y 为 0 或 S,R1 为正丙基的新型 D-6-n-propylergolines 及其药学上可接受的酸加成盐可用于降低哺乳动物的
催乳素水平或治疗人类帕
金森综合征的症状。 所述化合物的制备过程包括将 D-6-n-propyl-8a- mesyloxymethylergoline 与
甲硫醇钠盐或
甲酸钠反应。